Fear of disease progression in carriers of the m.3243A > G mutation [PDF]
Background Being diagnosed with mitochondrial disease due to the m.3243A > G mutation is frequently preceded by a long diagnostic process. The disease itself is characterized by heterogeneous course and expression, so leaving patients with considerable ...
José A. E. Custers +5 more
doaj +8 more sources
Fear of disease progression and relapse in multiple sclerosis: a systematic scoping review [PDF]
BackgroundMultiple sclerosis (MS) is a chronic disease of the central nervous system, most commonly affecting individuals in early adulthood. Uncertainty about future relapses and accumulating disability may lead to significant psychological distress ...
Arashk Mallahzadeh +7 more
doaj +4 more sources
Fear of disease progression among breast cancer patients in China: a meta-analysis of studies using the fear of progression questionnaire short form [PDF]
BackgroundFear of disease progression (FoP) is among the most prevalent and major psychological burdens breast cancer patients encounter. Excessive FoP may result in serious adverse effects for patients. FoP in breast cancer patients has gained attention
Jia-Li He +10 more
doaj +4 more sources
Factors associated with fear of disease progression among older spousal caregivers of cancer patients: a cross-sectional study [PDF]
Aim To describe the lever of fear of disease progression among older spousal caregivers of cancer patients in China and to explore the associated factors and their interrelationships.
Ruirui Qiu +6 more
doaj +3 more sources
Anxiety, depression and fear of disease progression among Chinese parents of children with retinoblastoma [PDF]
Background Recent studies indicate parents of childhood cancer survivors experience high psychological burden. However, there is limited knowledge regarding the mental health of parents of children with retinoblastoma (RB) in China.
Yilin Yu +6 more
doaj +3 more sources
Fear of Disease Progression in Patients with Type 2 Diabetes Construction and Validation of a Nomogram Prediction Model [PDF]
Xiaoxiao Liu,1,2 Junjun Wang,3 Haili Dong,2 Yanmin Zhao,4 Li Liu1 1Medical Insurance Department, Binzhou Medical University Hospital, Binzhou, Shandong, 256600, People’s Republic of China; 2College of Nursing, Binzhou Medical University, Binzhou ...
Liu X, Wang J, Dong H, Zhao Y, Liu L
doaj +3 more sources
Conflicting health information increases fear of disease progression in HPV-infected individuals: disease uncertainty as mediator and tolerance of uncertainty as buffer [PDF]
BackgroundHuman papillomavirus (HPV) infection is highly prevalent, and infected individuals frequently encounter HPV-specific conflicting health information about their condition. Although this phenomenon is well documented, the mechanisms by which such
Li Huai +4 more
doaj +4 more sources
Fear of disease progression and related factors among chronic disease patients attending South Wollo zone government hospitals [PDF]
Fear of disease progression is a common problem among patients with chronic disease. However, to the authors’ knowledge, it was not studied in Ethiopia. Thus, this study aimed to assess fear of disease progression and related factors among patients with ...
Sisay Gedamu Addis +7 more
doaj +2 more sources
Strategies and resources for coping with fear of disease progression in women with reproductive system cancer [PDF]
Fear of disease progression is one of the most common sources of psychological distress in patients suffering from chronic diseases. Fear of disease progression is a situationspecific and fully discernible (reportable) emotion based on personal ...
Moskovchenko, Denis V. +3 more
doaj +3 more sources
Current Status of Fear of Disease Progression in Patients with Advanced Cancer and Usefulness of Dignity Therapy Intervention. [PDF]
With changes in lifestyle and an increase in bad health habits, cancer has become a noncommunicable and frequently occurring disease that poses a serious threat to human life. Cancer is associated with high rates of morbidity and mortality worldwide.
Zhang Y, Zhou F, Yang H, Gong X, Gao J.
europepmc +3 more sources

